Prevalence of Psoriatic Arthritis in Adults with Psoriasis: An Estimate From Dermatology Practice
Phase 4
Withdrawn
- Conditions
- 10014982PsoriasisPsoriatic arthritis10023213
- Registration Number
- NL-OMON34134
- Lead Sponsor
- Pfizer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Subject has a confirmed diagnosis of plaque psoriasis by clinical judgement.
2. Subject is >18 years of age at the time of consent.
3. Subject is able to read and complete questionnaires.
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To evaluate the prevalence of PsA in subjects with psoriasis presenting to<br /><br>dermatologists* offices.</p><br>
- Secondary Outcome Measures
Name Time Method <p>To assess the prevalence of undiagnosed PsA in psoriasis subjects presenting to<br /><br>dermatologists*<br /><br>offices as determined by a clinical assessment by a rheumatologist.</p><br>